|
MechanismHCoV-229E S protein inhibitors [+3] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with hCoV HKU1
100 Translational Medicine associated with hCoV HKU1
0 Patents (Medical) associated with hCoV HKU1